Antidepressant electroconvulsive therapy: mechanism of action, recent advances and limitations.
about
Real-time self-regulation of emotion networks in patients with depressionDifferent regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depressionNeurological diseases and painFundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practices.ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: a comparative review.Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era.Mechanisms underlying the antidepressant response and treatment resistance.Electroconvulsive therapy: How modern techniques improve patient outcomes: Refinements have decreased memory loss, other adverse effects while retaining efficacy: Refinements have decreased memory loss, other adverse effects while retaining efficacyModulation of interhemispheric functional coordination in electroconvulsive therapy for depression.Resting-state functional connectivity modulation and sustained changes after real-time functional magnetic resonance imaging neurofeedback training in depression.Real-time FMRI neurofeedback training of amygdala activity in patients with major depressive disorder.Magnetic Seizure Therapy for Unipolar and Bipolar Depression: A Systematic Review.Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).Bilateral ECT induces bilateral increases in regional cortical thicknessIntroducing magnetic seizure therapy: A novel therapy for treatment resistant depression.Magnetic seizure therapy for treatment-resistant depression.The use of ECT and MST in treating depression.Genetic mechanisms of electroconvulsive therapy response in depression.Has electroconvulsive therapy use remained stable over time? A decade of electroconvulsive therapy service provision in Victoria, Australia.Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study.Orchestrated regulation of Nogo receptors, LOTUS, AMPA receptors and BDNF in an ECT model suggests opening and closure of a window of synaptic plasticity.New directions in the rational design of electrical and magnetic seizure therapies: individualized Low Amplitude Seizure Therapy (iLAST) and Magnetic Seizure Therapy (MST).Variation of plasma cortisol levels in patients with depression after treatment with bilateral electroconvulsive therapy.Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients.Electroconvulsive seizures stimulate the vegf pathway via mTORC1.Repeated treatment with electroconvulsive seizures induces HDAC2 expression and down-regulation of NMDA receptor-related genes through histone deacetylation in the rat frontal cortex.Amygdala Real-Time fMRI Neurofeedback for Major Depressive Disorder: A Review.
P2860
Q21134554-85FEF1C6-B4A2-45FC-A41B-F14C3BD30F4BQ24193570-4692C0A7-33DA-4C34-A16A-37D32C0122D1Q26822891-26183606-C9F7-4208-85A9-C2AB15913505Q30448586-C41A9319-8686-46D4-9BDB-0743B050985EQ30470391-CE159973-BE47-4E18-843E-CA894BD1D8D4Q33716723-87EC9616-804C-4405-A6CB-4A9BFB6D1A67Q33814386-D474695D-C031-4552-A340-338B7C209BEFQ34322171-E92BEA67-5C63-4AF0-A691-C96776198704Q34370422-2382D801-C270-459A-8C6F-098769AC175CQ34546626-7283561F-9E93-4262-A1ED-5BA8EC73AA96Q35093753-1F84925E-3656-4E94-84A2-9C4FD4492E9FQ35649683-B7B57250-FA64-4384-928C-31C23BCEB11BQ35816486-CCFB45B3-9EE5-4F86-ACD6-1861417244E3Q37254540-F9114FF9-8AE6-490F-861D-4B72C5D64696Q37766244-8B76854A-7A07-405A-AF0C-C32279CB5A52Q37949624-745A413F-964F-48A6-8197-C67ACCA47436Q37971397-CF6D7DFE-05CE-446E-AA5D-B0C0CF13F024Q38803609-5F043EDE-30F1-4005-ACC4-A19B0A84FE62Q39646754-D5C9FE63-2C78-4440-8D5B-2A76DEBDC03FQ42290537-3B7037AE-0F2B-4404-8373-45411C3360F5Q42906762-C72F429C-ED0E-4202-8A63-C92C2E68744AQ47347804-477B2F6E-F865-4CC2-A2A8-12E9A880400AQ48085955-D658C9F2-3870-4D2E-A633-147CBBEBAA5FQ48210559-FB97A399-FEC4-40AD-ACAB-5D23F3663E43Q48786438-CD210B59-F671-4F4D-96B5-9B841160CC00Q53292303-B25B3047-9FE5-406A-B296-3710548DC7D6Q53403447-D5CB8538-AD5C-41B2-BEC6-602C3380F8FE
P2860
Antidepressant electroconvulsive therapy: mechanism of action, recent advances and limitations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antidepressant electroconvulsi ...... cent advances and limitations.
@en
Antidepressant electroconvulsi ...... cent advances and limitations.
@nl
type
label
Antidepressant electroconvulsi ...... cent advances and limitations.
@en
Antidepressant electroconvulsi ...... cent advances and limitations.
@nl
prefLabel
Antidepressant electroconvulsi ...... cent advances and limitations.
@en
Antidepressant electroconvulsi ...... cent advances and limitations.
@nl
P2093
P1476
Antidepressant electroconvulsi ...... cent advances and limitations.
@en
P2093
Angela Merkl
Isabella Heuser
Malek Bajbouj
P356
10.1016/J.EXPNEUROL.2009.04.027
P407
P577
2009-05-05T00:00:00Z